| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 09/08/2005 | US20050196833 Cyclic GMP-binding, cyclic GMP-specific phosphodiesterase materials and methods |
| 09/08/2005 | US20050196832 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/08/2005 | US20050196829 identifying polymorphisms in gene sequences coding Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide (FCER1A); identifying modulator for prevention and treatment of allergic disorders |
| 09/08/2005 | US20050196807 Gene mining system and method |
| 09/08/2005 | US20050196806 Prostate specific antigen oligoepitope peptide |
| 09/08/2005 | US20050196805 Oligonucleotide primers for use as diagnostic tool in detection of plant bacterial pathogen of plants |
| 09/08/2005 | US20050196798 Nucleoside triphosphate diphosphohydrolase (NTPDASE 8) and uses thereof |
| 09/08/2005 | US20050196797 PI-3-kinase-related kinase polypeptide for use as tool in identifying modulators for prevntion and treatment of cell proliferation disorders |
| 09/08/2005 | US20050196788 isolated bacterial oxidase, comprising an oxidase that regenerates NADP+, NAD+, or both; isolated from Lactobacillus |
| 09/08/2005 | US20050196787 Antisense agents for use in treatment of diabetes and controlling blood lipid levels; gene expression inhibition |
| 09/08/2005 | US20050196781 RNA interference mediated inhibition of STAT3 gene expression using short interfering nucleic acid (siNA) |
| 09/08/2005 | US20050196769 Preparing DNA from paraffin-embedded, formalin-fixed tissue samples for promoter methylation analysis by deparaffinizing the samples; boiling them in citrate buffer; and extracting DNA from them; hypermethylation of ATM gene promoter correlates with decreased overall head & neck cancer survival |
| 09/08/2005 | US20050196767 siNA molecule comprising a double-stranded structure that down-regulates expression of GAB2 (Growth factor receptor-bound protein 2 (GRB2) , where the siNA molecule does not require the presence of nucleotides having a 2'-hydroxy group within the siNA molecule for mediating RNA interference |
| 09/08/2005 | US20050196765 siNA molecule comprising a double-stranded structure that down-regulates expression of checkpoint Kinase-1 (CHK-1), wherein said siNA molecule does not require the presence of nucleotides having a 2'-hydroxy group within the siNA molecule for mediating RNA interference |
| 09/08/2005 | US20050196759 Transductin-1 and transductin-2 and applications to hereditary deafness |
| 09/08/2005 | US20050196754 Nucleotide sequences coding modified immunoglobulin for use in immunodiagnostics and therapy |
| 09/08/2005 | US20050196753 Human coactivator-associated arginine methyltransferase 1 (hCARM1) |
| 09/08/2005 | US20050196751 Receptor protein is capable of activating transcription of desired gene when in presence of agonist and when bound to antagonist; gene therapy; gene expression inhibition; transgenic cells, animals |
| 09/08/2005 | US20050196750 Bioassay which utilizes invasive cleavage to identify single nucleotide polymorphism; genotyping and organismal classification |
| 09/08/2005 | US20050196425 Synthetic peptides having a non growth factor heparin binding region, a linker, and sequences; treatment of bone lesions, degenerative joint disease and to enhance bone formation |
| 09/08/2005 | US20050196406 Which display a passenger polypeptide on the outer surface of a biological entity; displayed passenger polypeptide is capable of interacting or binding with a given ligand |
| 09/08/2005 | US20050196405 Pneumococcal surface protein c (pspc), epitopic regions and strain selection thereof, and uses therefor |
| 09/08/2005 | US20050196399 antibody capable of specifically recognizing two regions of the A4 peptide/A beta 4, wherein the first region comprises the amino acid sequence AEFRHDSGY and the second region comprises the amino acid sequence YEVHHQKLVFFAEDVG |
| 09/07/2005 | EP1571157A1 LIPIN1 function |
| 09/07/2005 | EP1570090A2 A biological sample storage device and method for biological sample contamination testing |
| 09/07/2005 | EP1570085A2 Method for in vitro selection of 2'-substituted nucleic acids |
| 09/07/2005 | EP1570084A1 Methods for identifying functionally related genes and drug targets |
| 09/07/2005 | EP1570069A2 Compositions and methods for cell dedifferentiation and tissue regeneration |
| 09/07/2005 | EP1570043A2 Device and method for in-line blood testing using biochips |
| 09/07/2005 | EP1569695A2 Antisense modulation of apolipoprotein b expression |
| 09/07/2005 | EP1569675A2 Novel galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases |
| 09/07/2005 | EP1569661A2 Antisense design |
| 09/07/2005 | EP1451325A4 Transcription factor stress-related polypeptides and methods of use in plants |
| 09/07/2005 | EP1023308B1 Inhibitors of nucleoside metabolism |
| 09/07/2005 | CN1665938A Methods of detecting sequence differences |
| 09/07/2005 | CN1665937A Methods and compositions for determining methylation profiles |
| 09/07/2005 | CN1665837A Mutant proteins and use thereof for the manufacture of medicaments and the treatment of humans or animals suffering from conformational diseases |
| 09/07/2005 | CN1665830A Plasma or serum marker and process for detection of cancer |
| 09/07/2005 | CN1664107A DNA sequence coding for an a. thaliana protein with delta-5, 7-sterol-delta-7-reductase, the protein, process for the production, transformed yeast-strains and use |
| 09/07/2005 | CN1664098A Parkin gene mutation relating to Parkinson's disease and its detection method |
| 09/07/2005 | CN1663958A Nucleotide specific for escherichia coli 0134 O-antigen |
| 09/07/2005 | CN1663957A Micromolecule interference RNA aiming at middle period factor gene and use thereof |
| 09/06/2005 | US6939957 corresponding proteins with recombinant plasmids bearing the nucleotide sequences in Escherichia coli; nucleocapsid (NP) protein and phosphoprotein (P) |
| 09/06/2005 | US6939712 for expression inhibition/knockout of collagen, tumor necrosis factor, tat genes/proteins, and immunoglobulins |
| 09/06/2005 | US6939702 Lipase variant |
| 09/06/2005 | US6939701 Polypeptides having oxaloacetate hydrolase activity and nucleic acids encoding same |
| 09/06/2005 | US6939700 Isolated human aminoacylase, nucleic acid molecules encoding human aminoacylase, and uses thereof |
| 09/06/2005 | CA2160034C Gibbon ape leukemia virus-based retroviral vectors |
| 09/02/2005 | CA2499160A1 Releasable polymer arrays |
| 09/01/2005 | WO2005080606A1 Fluidic devices and methods for multiplex chemical and biochemical reactions |
| 09/01/2005 | WO2005080592A1 Method of immobilizing nucleic acid aptamers |
| 09/01/2005 | WO2005080431A2 Monoclonal antibodies that specifically bind to folate receptor alpha |
| 09/01/2005 | WO2005080411A1 3’-terminal nucleoside unit containing phosphoramidite |
| 09/01/2005 | WO2005080410A1 Targeted delivery of rna interference molecules for the treatment of ige-mediated disorders |
| 09/01/2005 | WO2005080404A1 Silyl linker for solid-phase synthesis of nucleic acid |
| 09/01/2005 | WO2005079367A2 Schizochytrium fatty acid synthase (fas) and products and methods related thereto |
| 09/01/2005 | WO2005079232A2 A METHOD FOR THE PRODUCTION OF AN ERYTHROPOIETIN ANALOG-HUMAN IgG FUSION PROTEINS IN TRANSGENIC MAMMAL MILK |
| 09/01/2005 | WO2005079196A2 Methods to identify evolutionarily significant changes in polynucleotide and polypeptide sequences in prokaryotes |
| 09/01/2005 | WO2005061734A3 Double stranded linear nucleic acid probe and uses thereof |
| 09/01/2005 | WO2005056786A3 Sugar kinases with expanded substrate specificity and their use |
| 09/01/2005 | WO2005052191A8 Compositions and methods for the diagnosis and treatment of tumor |
| 09/01/2005 | WO2005040187A3 The use of sirna silencing in the prevention of metastasis |
| 09/01/2005 | WO2005030967A3 Crop plant cystatin proteinase inhibitors and methods of use |
| 09/01/2005 | WO2005030966A3 Regulation of plant biomass and stress tolerance |
| 09/01/2005 | WO2005017113B1 Metalloproteinase gene polymorphism in copd |
| 09/01/2005 | WO2005001024A3 Genes encoding carotenoid compounds |
| 09/01/2005 | WO2004101809A3 Methods for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture |
| 09/01/2005 | WO2004101746A3 Production of carotenoids in microorganisms |
| 09/01/2005 | WO2004024076A8 Novel compositions and methods for the treatment of immune related diseases |
| 09/01/2005 | US20050192242 Therapeutic fusion protein transgenes |
| 09/01/2005 | US20050192239 Methods for identifying risk of breast cancer and treatments thereof |
| 09/01/2005 | US20050192238 Modulation of the expression of genes dependent on stat-1 |
| 09/01/2005 | US20050191760 Hermatically sealed device comprising solid support for use in isolation of DNA from bodily fluids, wastes, excretions and blood |
| 09/01/2005 | US20050191739 Polyphenol oxidase genes from banana, lettuce, tobacco and pineapple |
| 09/01/2005 | US20050191736 Polypeptides having cellulolytic enhancing activity andpolynucleotides encoding same |
| 09/01/2005 | US20050191733 Nucleotide sequences coding glucose transport protein for use in enhancement of foods, cosmetic and animal feeds |
| 09/01/2005 | US20050191732 Vector comprising nucleotide sequences coding homeostasis and adaptation (HA) proteins for use in enhancing/improving heterologous gene expression |
| 09/01/2005 | US20050191725 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/01/2005 | US20050191723 Improving gene expression in host cells vial use of vector comprising stabilizing anti-repressor (STAR) sequences; enhancer elements |
| 09/01/2005 | US20050191721 Tim-3 (t cell immunoglobulin and mucin domain containing molecule) polypeptide for use in enhancement of immune and transplantaion tolerance |
| 09/01/2005 | US20050191720 A vector for the surface expression of antibiotics composed of one or more genes that encode the synthetase and a gene encoding an amphiphilic peptide antibiotic having antibacterial, antifungal and anticancer activities; lactic acid-forming bacteria transformed with the vector |
| 09/01/2005 | US20050191700 Methods and compositions for producing biopolymeric arrays |
| 09/01/2005 | US20050191696 Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products |
| 09/01/2005 | US20050191689 Novel nucleic acid base pair |
| 09/01/2005 | US20050191687 Method for multiplexed analyte detection |
| 09/01/2005 | US20050191684 Transgenic gramnegative bacteria comprising enhanced 6-phosphogluconolactonase activity for fermentation of tryptophan, phenylalanine and tyrosine for use in cosmetics, medicine and animal feeds |
| 09/01/2005 | US20050191679 Schizochytrium fatty acid synthase (FAS) and products and methods related thereto |
| 09/01/2005 | US20050191674 Using genomic fragile sites as diagnostic tools in detection of cell proliferative disorders |
| 09/01/2005 | US20050191672 Nucleotide sequences for use in controlling expression of serine/threonine kinase and treatment and prevention of cell proliferative, autoimmune, inflammatory, cardiovascular and skin disorders |
| 09/01/2005 | US20050191666 Method of identification and cloning differentially expressed messenger RNAs |
| 09/01/2005 | US20050191660 Labelled oligonucleotides synthesized on solid-supports |
| 09/01/2005 | US20050191657 Such as 2-pyrrolidinone; an N-alkyl-pyrrolidinone; delta-valerolactam; and epsilon-caprolactam; kits |
| 09/01/2005 | US20050191656 Enhanced sequencing by hybridization using pools of probes |
| 09/01/2005 | US20050191654 Compositions and methods for diagnosing and treating chronic lymphocytic leukemia |
| 09/01/2005 | US20050191653 Oligonucleotide for use in controlling expression of sodium-dependent glucose cotransporters (SGLT2) gene sequenes and treatment of diabetes |
| 09/01/2005 | US20050191649 Identifying mutation in oligoadenylate synthetase gene (OAS1); identifying modulators for prevention and treatment of cell proliferative, nervous system and diabetic disorders |
| 09/01/2005 | US20050191648 Computer-directed assembly of a polynucleotide encoding a target polypeptide |
| 09/01/2005 | US20050191646 Nucleic acid analysis techniques |
| 09/01/2005 | US20050191638 Study and interfererance, diagnosis and treatment of polyglutamine using short interfering nucleic acid for treatment of dementia or siezures or muscular dystrophy |
| 09/01/2005 | US20050191634 Nucleotide sequences isolated via suppression subtractive hybridization for use as tool in detection of cell proliferative disorders |